BTG plc (LON:BTG – Get Free Report)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 840 ($11.10) and traded as high as GBX 840 ($11.10). BTG shares last traded at GBX 840 ($11.10), with a volume of 271,742 shares changing hands.
BTG Stock Performance
The company has a market capitalization of £3.26 billion and a PE ratio of 29.47. The firm’s 50-day simple moving average is GBX 840 and its 200 day simple moving average is GBX 840.
BTG Company Profile
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
See Also
- Five stocks we like better than BTG
- Energy and Oil Stocks Explained
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Compound Interest and Why It Matters When Investing
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- What is a support level?
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.